[HTML][HTML] The long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytes

SY Li, K Susztak - The Journal of clinical investigation, 2016 - Am Soc Clin Investig
SY Li, K Susztak
The Journal of clinical investigation, 2016Am Soc Clin Investig
An increasing amount of evidence suggests that metabolic alterations play a key role in
chronic kidney disease (CKD) pathogenesis. In this issue of the JCI, Long et al. report that
the long noncoding RNA (lncRNA) taurine-upregulated 1 (Tug1) contributes to CKD
development. The authors show that Tug1 regulates mitochondrial function in podocytes by
epigenetic targeting of expression of the transcription factor PPARγ coactivator 1α (PGC-1α,
encoded by Ppargc1a). Transgenic overexpression of Tug1 specifically in podocytes …
An increasing amount of evidence suggests that metabolic alterations play a key role in chronic kidney disease (CKD) pathogenesis. In this issue of the JCI, Long et al. report that the long noncoding RNA (lncRNA) taurine-upregulated 1 (Tug1) contributes to CKD development. The authors show that Tug1 regulates mitochondrial function in podocytes by epigenetic targeting of expression of the transcription factor PPARγ coactivator 1α (PGC-1α, encoded by Ppargc1a). Transgenic overexpression of Tug1 specifically in podocytes ameliorated diabetes-induced CKD in mice. Together, these results highlight an important connection between lncRNA-mediated metabolic alterations in podocytes and kidney disease development.
The Journal of Clinical Investigation